Presentation by Andreas Schleicher Tackling the School Absenteeism Crisis 30 ...
Supercritical Fluid Extraction of Bioactive Compounds from Natural Products
1. Supercritical Fluid Extraction of
Bioactive Compounds from
Natural Products
Prof. Sandra R.S. Ferreira
sandra@enq.ufsc.br
LATESC/EQA - CTC – UFSC
Chapecó – November, 2011
SRSFerreira - Chapecó, November, 2011
2. Summary
èNatural products èSFE vs low pressure
èBiological activities v Extraction yield
v Solute composition
èExtraction methods
v Antioxidant activity
èSFE v Antimicrobial activity
SRSFerreira - Chapecó, November, 2011 2
3. Natural Products
è Naturally occurring compounds or group of substances
èSources:
v Plants, fruits, animals, microorganisms, fungus, etc.
v Biological activities
èRelated areas:
v Medicine, food, flavoring and nutritional supplement
èDrugs and natural products? Newman & Cragg, 2007
v 1184 new chemicals approved (1981 to 2006)
Ø 52% natural product connection
Ø 18% are biologics
Ø 30% purely synthetic
SRSFerreira - Chapecó, November, 2011 3
4. Anticancer drugs
• B (Biological): isolated from
organism/cell or produced
biotechnologically
• N: Natural product
• ND: Derived from a natural
product
• S: Synthetic drug.
• S*: Synthetic, but similar to natural
product
• V: Vaccine.
All available anticancer drugs, 1940s-06/2006.
Newman and Cragg (2007). J. Nat. Prod., 70 (3), 461-477
SRSFerreira - Chapecó, November, 2011 4
5. Biological activity
è BA: properties and reactions of drugs related to their medicinal
value (Webster’s, 1993)
è Bioactivities:
v Anti-microbial, antioxidant, antifungal, antibacterial, cytotocxic (toxic to cells:
used as anti-cancer), enzymatic, antiviral, anti-inflammatory, anesthetic,
allelopathic (interfering herbs).
è Chemical profile:
v GC, GC-MS, HPLC, spectroscopy, X-ray difratometry, fluorescence,
spectrometry, chemometric methods (principal component analysis – PCA).
SRSFerreira - Chapecó, November, 2011 5
6. Few sources: 2008
Property - action Raw material (source) – substance Reference
Anti-HIV Hypericum H. chinese L. salicifolium, biyouyanagin A Nicolaou, et al., 2008.
Antimalarial/AM Manzamines: class of marine natural products Shilabin, et al., 2008
Melanoma cell reduction Dextrin Duncan et al., 2008.
Antibiotic Moenomycins, a potent family of natural product Yuan et al., 2008.
Antiproliferative activity Epothilones: macrocyclic bacterial natural products Feyen et al., 2008.
AM Latarcin from Spider venon Shlyapnikov et al., 2008.
AA Aminothiaxole (alkaloid from Dendrodoa grossularia). Strayo et al., 2008.
AA and AM Cynara cardunculus extracts Kukić et al., 2008.
AA Combine lycopene, b-carotene, vitamin E, vitamin C. Liu et al., 2008.
Antitumor antibiotics Lactimidomycin, iso-migrastatin and migrastatin Ju et al., 2008. In Press.
Cytotoxicity/genotoxicity Marine sponges: sources of alkaloid ingenamine G. Cavalcanti et al., 2008.
SRSFerreira - Chapecó, November, 2011 6
7. Few sources: 2011
Property - Raw material (source) – substance Reference
action
Antitumor glycans from green tea Fan et al., 2011.
Antitumor polysaccharides extracted from Zhao et al., 2011.
Asparagus officinali
Antimicrobial Eucalyptus globulus oil Tyagi & Malik, 2011
Antimicrobial Mentha piperita oil Tyagi & Malik, 2011
Antioxidant Food-derived peptidic antioxidants Samaranayaka et al,
2011
Antioxidant Marine Food Ngo et al., 2011
SRSFerreira - Chapecó, November, 2011 7
8. Bioactive extracts
èNatural products applied as extracts:
v Total or partial extracts, essential oil, oilresin...
èPhytotherapy:
v Study of the use of plants or plant extracts as health-promoting agents
èAmazon: huge natural reservoir
v 55,000 vegetable species cataloged from a total of 350,000 to 550,000
SRSFerreira - Chapecó, November, 2011 8
9. Important groups
è Alkaloids: high biological activity
v Anti-tumor, anti-spasmodic.
è Flavonoids: Present in flowers and fruits
v Blood vessels protectors, anti-inflammatory.
Alkaloid: caffeine
è Essential oils: Aromatic compounds
v Anti-septic and stimulant.
è Tannins: Phenolic compounds
v Ad stringent, bactericide and cicatrisation. Flavonoid
SRSFerreira - Chapecó, November, 2011 9
10. Raw
material Extraction vs extract
Pre- Separation /
treatment Extraction concentration
Separation steps used for isolation of plant metabolites
G. Romanik et al. J. Biochem. Biophys. Methods, 70 (2007) 253–261
SRSFerreira - Chapecó, November, 2011 10
12. Hydrodistillation
è Clevenger type apparatus
è Solvent: water
è Raw material:
v Soaked into water
è Essential oils
è High temperature
http://pagesperso-orange.fr/guy.chaumeton
SRSFerreira - Chapecó, November, 2011 12
13. Cold pressed extraction
è Used for vegetable and essential
oils from natural products
è Screw pressed extraction
è Low heat technique
http://www.abchansenafrica.co.za
SRSFerreira - Chapecó, November, 2011 13
14. Steam distillation
http://everestherbs.com.np
/
è Material placed into a still, pressurized steam passes
è Heat: globules of oil burst and oil evaporates
è Essential oil condensates in water cooled pipe
SRSFerreira - Chapecó, November, 2011 14
15. Solvent extraction
è Raw material and solvent: dissolve solute
è Solvent selection:
v Hydrocarbons, alcohols, ketone, acetic acid
v Polarity, solubility, solute interactions
è Solute/solvent separation
http://www.armfield.co.uk/
SRSFerreira - Chapecó, November, 2011 15
16. Maceration and soxhlet
è Raw matter soaked in solvent, è Reflux
heated and strained è High temperature
è Variables: time and temperature è Time consuming
è Solvent consuming
http://www.albrigi.co.uk
http://www.rsc.org/chemistryworld
SRSFerreira - Chapecó, November, 2011 16
17. Conventional extractions
èProblems:
vHigh temperatures
vSolvent contamination: reduces product quality
vInflammability or explosion risks
vTime, solvent and energy consuming
vComposition varies with solvent and extraction technique
SRSFerreira - Chapecó, November, 2011 17
18. New extraction methods
èASE: accelerated solvent extraction (Jaques et al., 2008)
v Pressurized extraction: high pressure (3000 psi) and temperature
v Good performance: break of solute–matrix interactions
èMAE: microwave assisted extraction (Wang et al., 2008)
v Less solvent consumption, shorter times, higher yields,
v Microwave plus solvent extraction: enhances efficiency.
èUSE: ultrasonic solvent extraction (Cuoco et al., 2008)
v Efficient contact (sample/solvent): increases efficiency
v Accelerates extraction due to disruption of cell walls.
SRSFerreira - Chapecó, November, 2011 18
19. SFE: alternative
èClassical methods:
v Limitations: time and solvent
consuming and energy costs
èSFE:
v Product quality:
Ø Solvent free
Ø Thermal degradation free
v Energy saving:
Ø Extraction + separation
http://www.nature.com
SRSFerreira - Chapecó, November, 2011 19
21. SFE: characteristics
SCF: intermediate properties between liquid and gas phases
State r x 103 [kg/m3] DAB x 104 [m2] m [kg/m.s]
Gas (0.6–2) x 10-3 0.1 – 0.4 (1–3) x 10-5
SCF
Pc; Tc 0.2 – 0.5 0.7 x 10-3 (1–3) x 10-5
4Pc; Tc 0.4 – 0.9 0.2 x 10-3 (3–9) x 10-5
Liquid 0.6 – 1.6 (0.2–2) x 10-5 (0.2–3) x 10-3
High mass transfer rates
SRSFerreira - Chapecó, November, 2011 21
22. Basic components
SOLVENT
PUMP
EXTRACTOR CO2: most used
solvent (304.2K
and 72.3bar)
SEPARATOR
SOLUTE
SRSFerreira - Chapecó, November, 2011 22
23. SFE: aspects
è Solvent power control (T/P)
è Fractionation
è Selectivity
è Extraction and separation:
v One step
SRSFerreira - Chapecó, November, 2011 23
24. SFE: applications
è Alternative process for high aggregated value products
è When quality is determinant
v Fine chemistry and pharmacy (active principles)
v Food (caffeine, hop, essential oils, aromas...)
è Sources:
v Plants, microorganisms, food, sea organisms, fungus…
è Examples:
v Food, colorants, drugs, vitamins, phyto-hormones
v Spices, coffee, aromas, oil seeds, hop, tobacco
v Wax, polymers, cleaning products…
SRSFerreira - Chapecó, November, 2011 24
26. P/T conditions
Extraction
Raw material Product
P (bar) T (oC)
Oily plants (crops) Soy oil Up to 700 Up to 50
Corn oil
Black pepper Black pepper oil 90 40
Piperine 200 40
Coffee Caffeine 300 80
Jojoba Jojoba oil 700 60
Green pepper Dye (color) 35 60
Hop Hop extract Up to 400 Up to 50
Chamomile Matricine ∼ 100 ∼ 40
Chrysanthemum Piretrine 250 40
Graichen & Hubert, (1994)
SRSFerreira - Chapecó, November, 2011 26
27. LATESC: raw materials
è Marigold (Calendula officinalis) è Apple pomace
è Horsetail (Equisetum giganteum) è Propolis
è Rice bran oil (Oryza sativa L.) è Peach almond
è Avenca-da-praia (Polygala cyparisias) è Shrimp shells
è Menthe (Mentha spicata) è Banana peel
è Rosemary (Rosmarinus officinalis L.) è Orange pomace
è Shiitake (Lentinula edodes) è Eucalypt leaves
è Grape pomace (Vitis vinífera) è Plumb
v Shiraz, Merlot, Cabernet sauvignon è Fishery by-products
è Erva baleeira (Cordia verbenacea) è Pecan nuts
è Spent Coffee ground and coffee husk è Shrimp residue
SRSFerreira - Chapecó, November, 2011 27
28. Extraction results
èProcess aspects:
v Extraction yield: cross-over influence
v Use of co-solvents in SFE: increase yield
èProduct quality:
v Extract composition: chromatographic methods
v Biological activities: antioxidant and antimicrobial activities
SRSFerreira - Chapecó, November, 2011 28
29. Peach almond
Peach
è Peach almond:
Products
v Industrial residue
v 32-55 % of oil
v Rich in fatty acids
Residue 20 % (oleic and linoleic)
Animal feed Oil extraction
SRSFerreira - Chapecó, November, 2011 29
31. SFE: co-solvents
èCO2: non-polar è Ethanol, methanol, propane...
v Dissolves non-polar v EtOH: legally accepted
v From 1% to 5% (w/w)
èCo-solvents: èInfluence:
v Volatility between solute/SCF v Composition
v Increase solubility v Biological activity
v Target compounds v Extraction yield
v Affect selectivity
SRSFerreira - Chapecó, November, 2011 31
32. SFE: Modifier
èImprove the SFE performance: yield and selectivity
èSelection: Ability to dissolve compounds of interest;
èCommon examples:
v EtOH, EtAc, DCM, BtOH
LATESC group:
è Campos et al. (2008): SFE from C. sauvignon grape pomace
v Increased yield from 2.7% to 9.2% by using 15% EtOH
è Biscaia & Ferreira (2009): SFE from propolis
v Increased yield from 8.6% to 24.8% by using 5% of EtOH
è Michielin et al. (2009): SFE from C. verbenacea
v Increased yield from 5.0% to 7.7% by using 5% of EtOH
è Mezzomo et al. (2010): SFE from peach almond
v Increased yield from 22% to 24% by using 5% of EtOH.
SRSFerreira - Chapecó, November, 2011 32
33. Extract quality
è Product quality as important as process yield
è Results (LATESC):
v Different raw materials
v Different extraction methods
Ø SFE (CO2 and CO2 + CS) and classical extraction methods
è Quality evaluation:
1. Chemical composition profile
2. Antioxidant activity
3. Antimicrobial activity
SRSFerreira - Chapecó, November, 2011 33
34. 1. Composition
èChromatographic methods
v Gas Chromatography: mostly for non-polar substances
Ø adequate for CO2 extracts
v HPLC: detect substances with higher polarity
èMass spectrometry:
v Components identification:
Ø Standard Reference Data Series of the National Institute of Standard
and Technology.
èComposition:
v Retention time and standard curves
SRSFerreira - Chapecó, November, 2011 34
35. Grape pomace
è Miolo winery Ltda. (Vintage 2003)
v Residue from wine production
v Cabernet Sauvignon, Merlot and
Shiraz
è Compounds remain in pomace
v Essential oil and pigments
v Resveratrol, linoleic acid
è Extract quality:
v Composition Grape pomace
v Fruit origin, harvest,
v Wine process, Campos, L.M.A.S.; Leimann, F.V., Curi, R.P.;
v Extraction/solvent method. Ferreira, S.R.S. Bioresource Technology,
99(17), 2008: 8413-8420.
SRSFerreira - Chapecó, November, 2011 35
36. GC-MS: grape pomace
No Components
For cosmetic products,
1 Phenyl ethyl alcohol synthesis vit. E
2 Capric acid
3 Lauric acid
4 Palmitic acid
5 Tridecanoic acid
6 Phytol
7 Linoleic acid
8 Ethyl linoleate
9 Oleic acid
10 Octadecanoic acid
11 Palmitaldehyde
12 Long chain linear acid GC-MS from grape pomace extract obtained by SFE
with pure CO2 at 150 bar, 40ºC and 3.33gCO2/min
SRSFerreira - Chapecó, November, 2011 36
42. Horsetail (Equisetum giganteum)
è Horsetail = cola de caballo.
è Actions:
v Anti-inflammatory, diuretic, anti-
hemorrhagic, skin regenerator
è Extraction:
v SFE, soxhlet and COSE
è Composition:
v GC-MS
SRSFerreira - Chapecó, November, 2011 42
44. GC-MS: Mentha spicata L
èGC-MS: menthe
v Carvone: antifungal and antimicrobial
v Pulegone: muscle reliever and for indigestion
v Phytol: diterpene alcohol used for vitamin E
synthesis and regulates metabolic process.
Compound SFE (CO2) Sox-EtOH SFE CO2+EtOH
Carvone 36.16 41.61 49.76
Pulegone 8.22 9.44 6.9
Phytol 8.11 4.61 11.13
Almeida et al. Food and
Bioproc. Tech. .IN PRESS.
SRSFerreira - Chapecó, November, 2011 44
45. 2. Antioxidant activity (AA)
è Ability to avoid or reduce oxidative rancidity (food deterioration)
è Synthetics (carcinogenic effect):
v BHA, BHT, TBHQ (phenols)
è Naturals (non toxic):
v From food products and plant material
v Tocopherols, ascorbic acid, phenolic compounds
è Several classes with diverse chemical behavior:
v AA result is dependant of the method
v One method: do not detect all mechanisms that characterize an AA.
SRSFerreira - Chapecó, November, 2011 45
46. Antioxidant methods
è Methods for AA%: Espectrophotometric and fluorescence methods
v Free radical scavenging methods
v Redox potential of antioxidants
è DPPH: (MENSOR et al. 2001)
v Radical (2,2-difenil-1-picrilhidrazil): electron capture from antioxidant
è ABTS:
v AA compounds: Ability to reduce radical ABTS•+ (600-750 nm)
è β-carotene/linoleic acid bleaching method (Matthäus, 2002)
v Suitable for lipophilic fractions: Ability to protect the lipid fraction from oxidation
è Total phenolic content (TPC):
v Folin-Ciocalteu colorimetric method [Singleton & Rossi, 1965]
v TPC was expressed as gallic acid equivalent (GAE)/mg of extracts
v For poly-phenols and mono-phenols
SRSFerreira - Chapecó, November, 2011 46
47. 3. Antimicrobial activity
èAntimicrobial substances:
v Prevent or inhibit microorganisms growth
èResistant bacteria:
v Challenge to infection treatments
v Patient sensibility to traditional antimicrobials
v New substances are necessary
èAntimicrobial compounds from plant material:
v Not well exploited
v Studies are very incipient.
SRSFerreira - Chapecó, November, 2011 47
48. Antimicrobial activity
è Agar diffusion method (ADM): inhibition ≥ 9mm selected for MIC
v S. Aureus, B. Cereus, M. luteus: Gram positive
v E. Coli, P. Aeruginosa: Gram negative
v C. Albicans, : fungus
è Minimum inhibition concentration (MIC)
v Positive result (Duarte et al., 2007):
Ø < 500 mg/mL: strong inhibitors
Ø 600 – 1500 mg/mL: moderate inhibitor.
SRSFerreira - Chapecó, November, 2011 48
49. Yield and DPPH: grape pomace
10 25
Yield AA %
8 20
Yield [%]
AA [%]
6 15
4 10
2 5
0 0
SFE 0% EtOHSFE 10% EtOHSFE 15% EtOHSFE 20% EtOH
ESC at 150 bar, 40ºC: AA by DPPH (sample at 250 µg/mL)
SFE: yield and AA
increase with EtOH
concentration
SRSFerreira - Chapecó, November, 2011 49
51. Grape Pomace – ADM results
ADM (mm)
Other low pressure extracts:
no antimicrobial activity
ADM: positive results: selected
for MIC
Baydar et al. (2004): grape peel extracts (not
active); grape seed extracts (highly active)
SRSFerreira - Chapecó, November, 2011 51
52. Antimicrobial activity: MIC
Extraction MIC (µg/mL)
Grape Process conditions
Method S. aureus B. cereus E. coli P. aeruginosa C. albicans
150 bar 750 ± 250 2000 >2000 >2000 -
200 bar 1500 ± 500 1000 >2000 >2000 500
Merlot 50 °C
250 bar 2000 1500 ± 500 >2000 >2000 -
300 bar 625 ± 375 1000 1000 1000 -
ESC CO2 150 bar 1000 1000 2000 2000 >2000
200 bar 1000 2000 2000 2000 -
Merlot 60 °C
250 bar 2000 2000 2000 2000 -
300 bar 1500 ± 500 1000 2000 2000 -
Syrah 60 °C 250 bar 1500 ± 500 2000 >2000 >2000 -
C. sauvignon 60 °C 250 bar 500 1000 >2000 >2000 -
Soxhlet Syrah hexane - 2000 - - -
SRSFerreira - Chapecó, November, 2011
53. AA% (DPPH): menthe
High AA for SFE
with co-solvent
SFE: CO2 SFE: CO2 + co-solvent Soxhlet
(bar/ºC) AA(%) (bar/ºC/EtOH%) AA(%) Solvent AA (%)
100/30 15 200/40/10% 70.3 Hx 30.5
100/40 26.7 200/40/15% 49.3 DCM 86.3
100/50 18.7 200/40/20% 71.4 EtAc 92.9
200/30 20.9 150/40/20% 38.2 BtOH 94.0
200/40 28.7 150/50/20% 84.4 EtOH 95.2
200/50 14.2 200/50/20% 24.5
300/30 22.6 230/40/20% 78.6
300/40 24.9 230/50/20% 35.3 HD AA (%)
300/50 24.2 Water 20.3
SRSFerreira - Chapecó, November, 2011 53
54. Shiitake (Lentinula edodes)
è 2° most consumed mushroom:
è Mushrooms: nutraceutic food
v Source of active compounds
v Cancer protection: Lentinan
v Anti-cholesterolemic: Eritadenina
v Antioxidant activity
v Antimicrobial activity
è Shiitake extract:
v 60 pills 500 mg = US$ 9.95
(http://www.vitacost.com)
SRSFerreira - Chapecó, November, 2011 54
55. AA%: Shiitake
IC50 (DPPH): Inhibition concentration SFE: AA%
ETA (equivalent of tanic acid): Total Phenolic Content similar to DCM
200 2.5
IC50
ETA
ETA (g/100 g extract)
160 2
120 1.5
IC50
80 1
40 0.5
0 0
Cose:DCM Cose:EtAc SF:EtOH 5% SF:EtOH SF:EtOH
10% 15%
Shiitake extract
Kitzberger et al., Journal of Food Engineering, 80(2): 631-638. 2007.
SRSFerreira - Chapecó, November, 2011 55
57. %AA Orange pomace: β-carotene/linoleic ac.
Extraction Solvent % AA (120 min)
ESC 40 ºC/100 bar CO2 84.4bcdefg ± 0.3
ESC 50 ºC/150 bar CO2 95b ± 4
ESC 40 ºC/200 bar CO2 82cdefgh ± 4
ESC 50 ºC/200 bar CO2 110a ± 3
ESC 50 ºC/250 bar CO2 90bcd ± 3
ESC 40 ºC/300 bar CO2 88bcdef ± 3
ESC 50 ºC/300 bar CO2 88bcde ± 2
ESC 50 ºC/250 bar CO2 + EtOH 92.5bc ± 0.2
BHT - 113a ± 7
Benelli et al. Journal of Supercritical Fluids, v. 55, p. 132-141, 2010.
SRSFerreira - Chapecó, November, 2011 57
58. Propolis
è Natural product used as
medicine purpose for centuries;
è Complex mixture:
v Resinous material from plant
sources, transferred by
enzymes (bee) and wax
(MARCUCCI et al., 2001).
http://www.natucentro.com.br/
è Component: artepilin C
SRSFerreira - Chapecó, November, 2011 58
59. AM: Propolis
method E. coli S. aureus B. cereus SFE (P/T) E. coli S. aureus B. cereus
100/30 13 19 16
Sox-EtOH 0 16 13 ADM (mm) 100/40 14 15 15
100/50 12 12 14
Sox-EtAc 0 14 13 150/30 0 15 16
Sox-CHCl3 0 14 12 150/40 13 17 20
Sox-Hex 0 18 14 150/50 0 21 20
200/30 0 16 21
Sox-H2O 0 14 10 200/40 0 15 15
COSE-EtOH 0 18 13 200/50 0 18 17
COSE-EtH2O 70% 0 14 14 250/40 0 16 18
COSE-EtH2O 50% 0 18 19
S. B.
Method E. coli aureus cereus
Sox-EtOH
Sox-Hx
NT
NT
0.2500
0.0625
0.5000
0.5000
MIC (mg/mL)
COSE:EtOH50% NT 1.0000 0.2500
SFE100/30 1.0000 0.1250 1.0000
SFE100/40 0.5000 0.2500 1.0000
SFE150/40 0.5000 0.1250 1.0000 SFE: excellent method for
SFE200/30 NT 0.0625 1.0000 antimicrobial extracts
SFE250/40 NT 0.0625 0.5000
SFE150/40/5% NT 0.0625 0.5000
SRSFerreira - Chapecó, November, 2011 59
60. Cordia verbenacea
è SC and SP shore;
v erva baleeira, salicilina (RAMOS et al., 2005, CARVALHO et al., 2004 ).
è Activities:
v anti-inflammatory and cicatrizing
v Rheumatism and attrite treatments
è Essential oils (aroma):
v a-humulene, b-caryophylene, pinene
è Flavonoids:
v quercetine, artemetin
www.jardimdeflores.com.br
SRSFerreira - Chapecó, November, 2011 60
61. DPPH: C. verbenacea
1200
C. verbenacea:
DPPH (EC50 g/mL)
800
Extracts with
excellent AA
400
0
Ac
H
t
x
Ac
CM
H
SE M
x
er
er
H
in
in
Ke
H
H
O
O
O
C
ut
at
et
at
Et
Et
SE
Et
D
Et
s
D
Et
x
rc
R
w
w
So
So
SE
x
x
%
SE
ue
x
O
x
So
%
So
So
So
50
C
O
25
Q
O
O
C
C
C
Extracts
COSE EtAc EC50= 9.2±0.4 mg/mL Soxhlet 50% EtOH EC50= 29±2 mg/mL
Rutin Ec50= 6.2±0.3 mg/mL
SRSFerreira - Chapecó, November, 2011 61
63. AM: C. verbenacea
Extract S. aureus B. cereus E. coli P. aeruginosa
SFE100bar/30 C 09 11 00 12
SFE100bar/50 C 15 15 00 11
SFE200bar/30 C 15 13 00 00
SFE200bar/40 C 31 12 00 00 ADM (mm)
SFE300bar/30 C 16 13 00 11
SFE300bar/40 C 15 13 00 10
CO2+ 5% EtAc 17 14 00 10
CO2+ 5% EtOH 15 12 00 09 All extracts present
COSE EtAc 19 16 00 11 AM against Gram +
COSE Water 20 13 00 00 bacteria
Sox 25% EtOH 25 15 16 21
Sox 50% EtOH 18 11 00 00
Sox EtOH 16 13 00 00
Sox Water 20 10 12 16
Sox EtAc 21 16 12 00
SRSFerreira - Chapecó, November, 2011 63
64. AM: C. verbenacea
Extract S. aureus B. cereus E. coli Pseudomona
aeruginosa
SFE 100/50 °C 1.000 0.125 NT >4.000
MIC (mg/mL)
SFE 200/40 °C 0.500 0.0468 NT NT
SFE 300/30 °C 0.375 < 0.0078 NT >4.000
CO2 + 5% EtAc 0.250 0.0156 NT >4.000
SFE: excellent
CO2 + 5% EtOH 0.250 0.03125 NT 1.000
method for highly
Mac EtAc 0.250 0.0468 NT 1.500
effective AM
Sox 25% EtOH 2.000 1.000 2.000 1.000
Sox Water 2.000 2.000 2.000 1.000
Sox Hx NT NT 2.000 >4.000
Sox EtAc 0.500 0.0468 2.000 NT
MIC (Positive result): < 0.5 mg/mL: strong inhibitors
SRSFerreira - Chapecó, November, 2011 64
65. Economic issues
è Last 15 years (natural products):
v More than 100 plants (pilot and industrial scales) in operation
è Small to medium units:
v 100 to 1000 ton/year at 3 to 4 EUR/kg product
è Industrial units:
v 10.000 ton/year at 0.5 EUR/kg product
è Natural products (3% extract)
v Cost: 100 to150 EUR/kg product
v Continuous process: cost reduction in 5 times
SRSFerreira - Chapecó, November, 2011 65
66. Conclusion
èExtraction method and process conditions affect:
v Extraction yield
v Chemical profile
v Biological activity
èSFE: relevant technology for biological active extracts
v Screening
v Process optimization
v Product standardize
v Costs Good idea!
SRSFerreira - Chapecó, November, 2011 66
67. Federal University of Santa Catarina
Chemical and Food
Engineering Department
EQA/CTC – UFSC, P.O. Box 476
Florianópolis, SC – BRAZIL
ZIP Code 88040-900
Phone: + 55 48 3721.9448
FAX: + 55 48 3721.9687
www.enq.ufsc.br
SRSFerreira - Chapecó, November, 2011 67
68. References
è MENSOR, et al. Phitoterapy Research. v. 15, p. 27-130.
è SAUCEAU, M. J.of Supercritical Fluids 31 (2004) 133-140.
è SOVOVÁ, H. J. Chem. Data 2001, 46, 1255-1257.
è CHAFER et al., J. of Supercritical Fluids 32 (2004) 89-96.
è BOHN, J.; BEMILLER, J.N. Carbohydrate Polymers, USA, 28, 3-14, 1995.
è Campos, L.M.A.S.; Leimann, F.V., Curi, R.P.; Ferreira, S.R.S. Bioresource Technology, 99(17), 2008: 8413-8420.
è C. M. P. Sarmento, S. R. S. Ferreira; H. Hense. BJChE (IN PRESS). BJChE, 23(2): 243 – 249. 2006.
è Nicolaou, K. C.; Wu, T. R.; Sarlah, D.; Shaw, D. M.; Rowcliffe, E.; Burton, D. R. J. Am. Chem. Soc.; 2008; In Press.
è Shilabin, A. G.; Kasanah, N.; Tekwani, B. L.; Hamann, M. T. J. Nat. Prod.; (Article); 2008; 71(7); 1218-1221.
è Duncan, R.; Gilbert, H. R. P.; Carbajo, R. J.; Vicent, M. J. Biomacromolecules; (Article); 2008; 9(4); 1146-1154.
è Yuan Y. ; Fuse S. ; Ostash B. ; Sliz P. ; Kahne D. ; Walker S. ACS Chem. Biol.; (Article); 2008; 3(7); 429-436.
è Feyen, F.; Cachoux, F.; Gertsch, J.; Wartmann, M.; Altmann, K. Acc. Chem. Res.; (Article); 2008; 41(1); 21-31.
è Shlyapnikov et al. Protein Expression and Purification, 60(1) 2008: 89-95.
è Strayo et al. Devasagayam. Chemico-Biological Interactions, 173(3). 2008: 215-223.
è Kukić et al. Food Chemistry, 107 (2). 2008: 861-268.
è Liu et al. LWT - Food Science and Technology, 41(7) 2008: 1344-1349.
è Ju et al. Bioorg. & Medicinal Chemistry Letters, 2008.
è Cavalcanti et al. Comparative Biochemistry and Physiology Part C: Toxicology & Pharmacology, 147(4). 2008 409-415.
è G. Romanik et al. J. Biochem. Biophys. Methods 70 (2007) 253–261
è Michielin, E.M.Z.; Bresciani, L. F.V.; Danielski, L.; Yunes, R.A.; Ferreira, S.R.S. J. Supercritical Fluids. 2005. V 33: 131.
è Kitzberger et al., Journal of Food Engineering, 80(2): 631-638. 2007.
è Danielski et al. Chem. Eng. Proc., 46 (2). 2007: 99-106.
SRSFerreira - Chapecó, November, 2011 68